Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis.
Level 5 - mechanism / opinion, no new human data
In vitro bench research using cell culture and cybrid models
PubMed 15979824 · doi:10.1016/j.gene.2005.03.027
What was done
Researchers investigated whether mitochondrial genome depletion affects nuclear genome stability and promotes tumorigenesis using human cell culture models and cybrid cell technology. They generated mitochondrial DNA-depleted (rho0) cells, assessed chromosomal instability and transformation phenotypes, evaluated the expression and regulation of the DNA repair and transcriptional regulator APE1 (Ref1/HAP1), examined the effects of repopulating rho0 cells with wild-type mitochondria, and assessed APE1 expression across primary tumor samples.
What was found
Mitochondrial DNA depletion in human cells led to chromosomal instability, induced a transformed cellular phenotype, and altered APE1 expression. Exogenous transfer of wild-type mitochondria into rho0 cells reversed both the altered APE1 expression and the tumorigenic phenotype. APE1 expression was also reported to be altered in a variety of primary tumors. The abstract reports no numerical values, sample counts, effect sizes, or statistical metrics.
Why it matters
This study provides mechanistic evidence that mitochondrial genetic status directly influences nuclear genome integrity and cellular transformation, identifying APE1 as a key mediator of mito-nuclear cross talk in cancer biology.
Limits
The findings derive primarily from in vitro cell models and cybrid experiments, which may not reflect in vivo tumor development. The abstract provides no quantitative data, variance estimates, specific cell line identities, or sample sizes for the primary tumors analyzed.
Cited by
- supports Nuclear transfer experiments show that normal cytoplasm/mitochondria suppress tumorigenicity even in the presence of an abnormal cancer nucleus, challenging the somatic mutation theory.